GREENWICH, Conn.--(BUSINESS WIRE)--Aptuit, Inc. announced today that it has completed the acquisitions of EaglePicher Pharmaceutical Services, LLC, (EPPS) and SSCI, Inc., adding active pharmaceutical ingredient (API) development and manufacture as well as industry-leading solid-state chemistry to its portfolio of drug development services. The acquisitions further enable Aptuit to streamline the API development and supply process for customers as well as to help them gain a better understanding of their compound’s characterization profile up front to minimize delays and reduce the time and cost of commercialization.
